Hypnotic Pediatric Studies Should Explore Endpoints Distinct From Adults
Executive Summary
New pediatric indications should be identified for trials of hypnotics because of difficulty categorizing pediatric sleep disorders as either transient or primary insomnia, FDA's Pediatric Advisory Subcommittee said Nov. 16.